Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 3/20 | 0.51 |
| ▸ | STS | P08842 | 4/20 | 0.49 |
| ▸ | SFRP1 | Q8N474 | 3/20 | 0.47 |
| ▸ | CCR8 | P51685 | 1/20 | 0.46 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8022249 | 0.91 | STS (0.53) | BRD4STSSFRP1CCR8USP30 | |
| SCHEMBL8023062 | 0.87 | SFRP1 (0.51) | BRD4STSSFRP1CCR8 | |
| SCHEMBL7982132 | 0.87 | STS (0.57) | BRD4STSSFRP1CCR8USP30 | |
| SCHEMBL8004225 | 0.85 | L3MBTL1 (0.50) | BRD4STSSFRP1CCR8ALDH1A1 | |
| SCHEMBL3813973 | 0.85 | ACLY (0.45) | SFRP1ALDH1A1L3MBTL1 | |
| SCHEMBL4734403 | 0.80 | STS (0.54) | BRD4STSSFRP1CCR8 | |
| SCHEMBL4618399 | 0.78 | SFRP1 (0.70) | SFRP1CCR8 | |
| SCHEMBL8015057 | 0.78 | USP30 (0.57) | BRD4STSSFRP1CCR8USP30 | |
| SCHEMBL1320324 | 0.78 | STS (0.55) | BRD4STSSFRP1CCR8NPC1 | |
| SCHEMBL6194827 | 0.78 | STS (0.55) | BRD4STSSFRP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264499-A1 | Cathepsin C Inhibitors | GLAXO GROUP LIMITED (GB) | 2009-10-22 | — | — | US | disclosed |
| WO-2009129371-A1 | CATHEPSIN C INHIBITORS | GLAXO GROUP LIMITED (GB) | 2009-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264499-A1 | Cathepsin C Inhibitors | CTSB, CTSF, CTSG | BRD4 1848/4885STS 3498/4885SFRP1 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.